Rediscover intimacy.
A doctor-guided program for desire, arousal and comfort — personalised treatment plus ongoing support, delivered discreetly to your door.
If it has changed, there is usually a reason.
Sexual difficulties in women are common and often have identifiable contributing factors — hormonal change, medication, pain, sleep, stress, relationship context or a combination.1 Very few women raise it with a doctor.2
Interest that has dropped, or gone, and bothers you.
Dryness, irritation or pain that makes sex something to avoid.
Physical response or climax that has become harder to reach.
Feeling disconnected from your body or avoiding intimacy.
Three possible routes, decided by your doctor.
Which route suits you depends on what you’re experiencing and your medical history. Some options are prescription-only and are discussed by name only once you have been assessed and are logged in.
A locally applied, prescription-only option for women whose main concern is comfort and tissue health. Applied at home, nothing systemic.
A low-dose, prescription-only option where physical arousal and responsiveness are the concern. Suitability depends on your history and other medication.
A non-prescription option to support intimate comfort and skin health day to day. Can be used alongside a prescribed route where appropriate.
Three steps. No bloods, no examination.
Free 3-minute check
A written questionnaire about what you’re experiencing, your history and your medication. Nobody phones you.
A doctor reviews it
An HPCSA-registered doctor decides which route is appropriate, or declines if none is. This pathway needs no blood tests.
Delivered & supported
Dispensed by a licensed pharmacy in plain packaging, with follow-up check-ins in writing.
Real reviews from real women.
Femlab
Your questions, answered.
Do I need blood tests for this?+
No. This pathway is assessed from your written questionnaire and medical history. If the doctor thinks bloods would change the picture — for example if your symptoms point to a wider hormonal change — they’ll tell you and may suggest the hormone pathway instead.
Will I have to talk to someone about this?+
Not unless you want to. The consultation happens in writing. If you’d rather speak to the doctor you can ask for that, but it’s never required for this pathway.
Is there an examination?+
No physical examination forms part of this pathway. If your answers suggest something that should be examined in person — unexplained bleeding, a lump, or pain with other symptoms — we’ll tell you to see a clinician face to face rather than treat it online.
Can I use this if I’m on other medication?+
List everything you take in the assessment. Some options interact with common medicines, including certain heart and blood-pressure medications, and the doctor will rule those out.
How will it arrive?+
Couriered in plain, unbranded packaging with nothing on the outside indicating what’s inside or who sent it.
What if I’m not approved?+
If the doctor decides no option here is right for you, the review fee is refunded and they’ll explain what would be a better next step.
You don’t have to bring it up. Just start the check.
Free, private, three minutes. A registered doctor reviews your answers before anything is decided.
Sources
References & compliance notes
+
Every factual statement on this page is numbered to a source. Items marked for confirmation must be verified or removed before publishing.
- Prevalence and contributing factors for female sexual dysfunction — proposed source: a peer-reviewed review or ISSWSH/IUGA guidance. [CITATION TO BE CONFIRMED BY MEDICAL TEAM — no figure is stated on the page until this is supplied]
- Rates at which women raise sexual difficulties with a clinician. [CITATION TO BE CONFIRMED — remove the claim if no source is available]
- Health Professions Council of South Africa. General Ethical Guidelines for Good Practice in Telemedicine (Booklet 10). Basis for teleconsultation and doctor-registration statements.
- Protection of Personal Information Act 4 of 2013 (POPIA). Basis for the confidentiality statement.
- Republic of South Africa. Medicines and Related Substances Act 101 of 1965, General Regulations, Regulation 42(1)–(2); read with SAHPRA Guidelines for Advertisement of Medicines and Health Products, SAHPGL-INSP-RC-07. Only non-prescription medicines may be advertised to the public.
FemLab provides access to independent medical assessment and healthcare support by HPCSA-registered practitioners. Treatment is provided only where clinically appropriate following a doctor’s review, and not everyone will qualify. All medicines have potential risks, side effects and contraindications. This page is general information and is not medical advice or a substitute for individual assessment. Reviews reflect individual experiences; results vary.